A role for inflammatory mediators in the induction of immunoregulatory B cells

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4810-4817

  Matsumura, Yumi ^a   Byrne, Scott N ^a   Ngheim, Dat X ^a,b   Miyahara, Yasuko ^a   Ullrich, Stephen E ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID METHYL 2 PHENYLTHIOETHYL ESTER; CD11B ANTIGEN; CD19 ANTIGEN; CD45 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN P 15095; INTERLEUKIN 10; SEROTONIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CANCER; ULTRAVIOLET RADIATION;

EID: 33749123725     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4810     Document Type: Article

References (56)

1. Boring, C. C., T. S. Squires, and T. Tong. 1992. Cancer statistics. CA Cancer J. Clin. 42: 19-38.
2. Ullrich, S. E. 2002. Photoimmune suppression and photocarcinogenesis. Frontiers Biosci. 7: D684-D703.
3. Noonan, F. P., E. C. De Fabo, and M. L. Kripke. 1981. Suppression of contact hypersensitivity by ultraviolet radiation: an experimental model. Springer Semin. Immunopathol. 4: 293-304.
4. Ullrich, S. E. 1986. Suppression of the immune response to allogeneic histocompatibility antigen by a single exposure to UV radiation. Transplantation 42: 287-291.
5. Howie, S. E. M., M. Norval, and J. Maingay. 1986. Exposure to low dose UVB light suppresses delayed type hypersensitivity to herpes simplex virus in mice. J. Invest. Dermatol. 86: 125-128.
6. Jeevan, A., and M. L. Kripke. 1989. Effect of a single exposure to ultraviolet radiation on Mycobacterium bovis Bacillus Calmette-Guerin infection in mice. J. Immunol. 143: 2837-2843.
7. Denkins, Y., I. J. Fidler, and M. L. Kripke. 1989. Exposure of mice to UVB radiation suppresses delayed hypersensitivity to Candida albicans. Photochem. Photobiol. 49: 615-619.
8. Garssen, J., W. Goettsch, F. de Gruijl, W. Slob, and H. van Loveren. 1996. Risk assessment of UVB effects on resistance to infectious diseases. Photochem. Photobiol. 64: 269-274.
9. Nghiem, D. X., N. Kazimi, G. Clydesdale, H. N. Ananthaswamy, M. L. Kripke, and S. E. Ullrich. 2001. Ultraviolet A radiation suppresses an established immune response: implications for sunscreen design. J. Invest. Dermatol. 117: 1193-1199.
10. Barber, L. A., D. F. Spandau, S. C. Rathman, R. C. Murphy, C. A. Johnson, S. W. Kelley, S. A. Hurwitz, and J. B. Travers. 1998. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J. Biol. Chem. 273: 18891-18897.
11. Pei, Y., L. A. Barber, R. C. Murphy, C. A. Johnson, S. W. Kelley, L. C. Dy, R. H. Fertel, T. M. Nguyen, D. A. Williams, and J. B. Travers. 1998. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J. Immunol. 161: 1954-1961.
12. Ramos, G., N. Kazimi, D. X. Nghiem, J. P. Walterscheid, and S. E. Ullrich. 2004. Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. Toxicol. Appl. Pharmacol. 195: 331-338.
13. Walterscheid, J. P., S. E. Ullrich, and D. X. Nghiem. 2002. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 195: 171-179.
14. 2, interleukin-4, and interleukin-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160: 3783-3789.
15. Niizeki, H., and J. W. Streilein. 1997. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol. 109: 25-30.
16. Okamoto, H., and M. L. Kripke. 1987. Effector and suppressor circuits of the immune response are activated in vivo by different mechanisms. Proc. Natl. Acad. Sci. USA 84: 3841-3845.
17. Vink, A. A., A. M. Moodycliffe, V. Shreedhar, S. E. Ullrich, L. Roza, D. B. Yarosh, and M. L. Kripke. 1997. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc. Natl. Acad. Sci. USA 94: 5255-5260.
18. Vink, A. A., F. M. Strickland, C. Bucana, P. A. Cox, L. Roza, D. B. Yarosh, and M. L. Kripke. 1996. Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J. Exp. Med. 183: 1491-1500.
19. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
20. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426.
21. Ishii, S., T. Kuwaki, T. Nagase, K. Maki, F. Tashiro, S. Sunaga, W. H. Cao, K. Kume, Y. Fukuchi, K. Ikuta, et al. 1998. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187: 1779-1788.
22. Moodycliffe, A. M., D. Nghiem, G. Clydesdale, and S. E. Ullrich. 2000. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 1: 521-525.
23. Kripke, M. L., and E. McClendon. 1986. Studies on the role of antigen-presenting cells in the systemic suppression of contact hypersensitivity by UVB radiation. J. Immunol. 137: 443-447.
24. + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100: 383-390.
25. Rivas, J. M., and S. E. Ullrich. 1992. Systemic suppression of DTH by supernatants from UV-irradiated keratinocytes: an essential role for keratinocyte-derived interleukin 10. J. Immunol. 149: 3865-3871.
26. Schmiti, D. A., and S. E. Ullrich. 2000. Exposure 10 ultraviolet radiation causes dendritic cells/macrophages to secrete immune suppressive IL-12p40 homodimers. J. Immunol. 165: 3162-3167.
27. Fernandez-Gallardo, S., M. P. Ortega, J. G. Priego, M. F. de Casa-Juana, C. Sunkel, and M. Sanchez Crespo. 1990. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies. J. Pharmacol. Exp. Ther. 255: 34-39.
28. Martins, M. A., M. C. Lima, P. T. Bozza, H. C. Faria Neto, P. M. Silva, C. E. Sunkel, and R. S. Cordeiro. 1993. Interference of the PAF receptor antagonist, PCA 4248, with the rat pleurisy evoked by inflammatory mediators or allergen. Eur. J. Pharmacol. 237: 17-22.
29. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258: 1156-1159.
30. Eynon, E. E., and D. C. Parker. 1993. Parameters of tolerance induction by antigen targeted to B lymphocytes. J. Immunol. 151: 2958-2964.
31. Hollsberg, P., V. Batra, A. Dressel, and D. A. Hafler. 1996. Induction of anergy in CD8 T cells by B cell presentation of antigen. J. Immunol. 157: 5269-5276.
32. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
33. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
34. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
35. Olson, T. S., G. Bamias, M. Naganuma, J. Rivera-Nieves, T. L. Burcin, W. Ross, M. A. Morris, T. T. Pizarro, P. B. Ernst, F. Cominelli, and K. Ley. 2004. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J. Clin. Invest. 114: 389-398.
36. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69: 419-445.
37. Mossner, R., and K. P. Lesch. 1998. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav. Immun. 12: 249-271.
38. Lesch, K. P., and R. Mossner. 1998. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol. Psychiatry 44: 179-192.
39. Matsuda, H., H. Ushio, G. P. Geba, and P. W. Askenase. 1997. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J. Immunol. 158: 2891-2897.
40. Slominski, A., J. Wortsman, and D. J. Tobin. 2005. The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J. 19: 176-194.
41. Nguer, C. M., O. Pellegrini, P. Galanaud, J. Benveniste, Y. Thomas, and Y. Richard. 1992. Regulation of paf-acether receptor expression in human B cells. J. Immunol. 149: 2742-2748.
42. Nguer, C. M., D. Treton, M. Rola-Pleszczynski, Z. Mishal, Y. Thomas, P. Galanaud, and Y. Richard. 1996. Regulation of platelet-activating factor receptor expression in human B cells and B cell lines. Lipids 31: 1051-1058.
43. Bastien, Y., B. J. Toledano, N. Mehio, L. Cameron, B. Lamoukhaid, P. Renzi, Q. Hamid, and B. D. Mazer. 1999. Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes. J. Immunol. 162: 5498-5505.
44. Fisher, M. S., and M. L. Kripke. 1982. Suppressor T lymphocytes control the development of primary skin cancers in UV-irradiated mice. Science 216: 1133-1134.
45. Schwarz, A., S. Beissert, K. Grosse-Heitmeyer, M. Gunzer, J. A. Bluestone, S. Grabbe, and T. Schwarz. 2000. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J. Immunol. 165: 1824-1831.
46. Shreedhar, V. K., M. W. Pride, Y. Sun, M. L. Kripke, and F. M. Strickland. 1998. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J. Immunol. 161: 1327-1335.
47. Kripke, M. L., C. G. Munn, A. Jeevan, J. M. Tang, and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145: 2833-2838.
48. Alard, P., I. Kurimoto, H. Niizeki, J. M. Doherty, and J. W. Streilein. 2001. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin requires mast cell degranulation. Eur. J. Immunol. 31: 1736-1746.
49. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617.
50. 2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159: 28-35.
51. 2 is a selective inducer of interleukin-12 p40 (IL- 12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97: 3466-3469.
52. Byrne, S. N., and G. M. Halliday. 2005. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J. Invest. Dermatol. 124: 570-578.
53. Ishii, S., and T. Shimizu. 2000. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog. Lipid Res. 39: 41-82.
54. Darst, M., M. Al-Hassani, T. Li, Q. Yi, J. M. Travers, D. A. Lewis, and J. B. Travers. 2004. Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line. J. Immunol. 172: 6330-6335.
55. Ullrich, S. E. 1999. Dermal application of JP-8 jet fuel induces immune suppression. Toxicol. Sci. 52: 61-67.
56. Ullrich, S. E., and H. J. Lyons. 2000. Mechanisms involved in the immunotoxicity induced by dermal application of JP-8 jet fuel. Toxicol. Sci. 58: 290-298.